Wells Fargo & Company »

Indaptus Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Indaptus Therapeutics (INDP) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Indaptus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Indaptus Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indaptus Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $235 105 2.24
2023-12-31 $182 104 1.75
2023-09-30 $281 102 2.76
2023-06-30 $193 101 1.92
2022-12-31 $142 98 1.45
2022-09-30 $0 97 0.00
2022-06-30 $0 101 0.00
2022-03-31 $0 98 0.00
2021-12-31 $0 398 0.00
2021-09-30 $0 64 0.00